Literature DB >> 12120248

Cystic neoplasms of the pancreas.

C Fernández-del Castillo1, A L Warshaw.   

Abstract

Cystic tumors of the pancreas have become increasingly prevalent. In large series, more than 90% of pancreatic cystic neoplasms are accounted for by mucinous cystadenomas and cystadenocarcinomas, serous cystadenomas, and intraductal papillary mucinous tumors. Differentiating cystic neoplasms from pseudocysts can almost always be accomplished by clinical and radiological means, but in doubtful cases, when observation is contemplated, or when it is important to determine preoperatively the type of cystic neoplasm, cyst fluid analysis is useful. This can be readily obtained by endoscopic ultrasound, and analysis of enzymes, viscosity, cytology and a variety of tumor markers allows for a better differential diagnosis.

Entities:  

Mesh:

Year:  2001        PMID: 12120248     DOI: 10.1159/000055875

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  11 in total

1.  Pancreatic serous oligocystic adenomas: clinicopathologic features and a comparison with serous microcystic adenomas and mucinous cystic neoplasms.

Authors:  Brian K P Goh; Yu-Meng Tan; Wai-Ming Yap; Peng-Chung Cheow; Pierce K H Chow; Yaw-Fui Alexander Chung; Wai-Keong Wong; London L P J Ooi
Journal:  World J Surg       Date:  2006-08       Impact factor: 3.352

2.  Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment.

Authors:  Jennifer F Tseng; Andrew L Warshaw; Dushyant V Sahani; Gregory Y Lauwers; David W Rattner; Carlos Fernandez-del Castillo
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

Review 3.  Approach to cystic lesions of the pancreas.

Authors:  Roland M Schmid; Jens T Siveke
Journal:  Wien Med Wochenschr       Date:  2013-11-20

Review 4.  Cystic neoplasms of the pancreas.

Authors:  Hop S Tran Cao; Benjamin Kellogg; Andrew M Lowy; Michael Bouvet
Journal:  Surg Oncol Clin N Am       Date:  2010-04       Impact factor: 3.495

Review 5.  Less common neoplasms of the pancreas.

Authors:  Abby-L Mulkeen; Peter-S Yoo; Charles Cha
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

6.  Is serous cystadenoma of the pancreas a model of clear-cell-associated angiogenesis and tumorigenesis?

Authors:  Duangpen Thirabanjasak; Olca Basturk; Deniz Altinel; Jeanette D Cheng; N Volkan Adsay
Journal:  Pancreatology       Date:  2008-12-13       Impact factor: 3.996

7.  Histological percutaneous diagnosis of stage IV microcystic serous cystadenocarcinoma of the pancreas.

Authors:  Bassam Abu Wasel; Valerie Keough; Weei-Yuan Huang; Michele Molinari
Journal:  BMJ Case Rep       Date:  2013-01-30

Review 8.  Management of serous cystadenoma of the pancreas.

Authors:  Jennifer F Tseng
Journal:  J Gastrointest Surg       Date:  2007-10-25       Impact factor: 3.452

Review 9.  Cystic neoplasms of the pancreas: a diagnostic challenge.

Authors:  Grant F Hutchins; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

10.  Defining criteria for selective operative management of pancreatic cystic lesions: does size really matter?

Authors:  Eugene P Ceppa; Sebastian G De la Fuente; Srinevas K Reddy; Sandra S Stinnett; Bryan M Clary; Douglas S Tyler; Theodore N Pappas; Rebekah R White
Journal:  J Gastrointest Surg       Date:  2010-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.